Learn More
Medchemexpress LLC Futibatinib | 1448169-71-8 | MFCD29037352 | 99.9% | 418.45 g/mol | C22H22N6O3 | 5 MG

Supplier: Medchemexpress LLC HY1008185MG
Futibatinib is an orally bioavailable, irreversible FGFR1-4 inhibitor supplied as a research-grade powder intended for analytical and preclinical laboratory research. It targets fibroblast growth factor receptors and shows low-nanomolar potency against FGFR1-4, including activity against several FGFR2 mutants.
- Potent irreversible FGFR inhibitor with low-nanomolar activity.
- Active against wild-type and mutant FGFR2 variants.
- Supplied as a research-grade powder for analytical applications.
- Molecular formula C22H22N6O3 and molecular weight 418.45 g/mol.
- Intended for laboratory research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.